Scarica l'app Stockscreener
20.69
1.42%
0.29
Dopo l'orario di chiusura:
20.78
0.09
+0.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$20.40
Aprire:
$20.28
Volume 24 ore:
15.28M
Relative Volume:
1.92
Capitalizzazione di mercato:
$10.64B
Reddito:
$10.89B
Utile/perdita netta:
$-241.00M
Rapporto P/E:
-77.90
EPS:
-0.2656
Flusso di cassa netto:
$340.00M
1 W Prestazione:
+8.27%
1M Prestazione:
+13.93%
6M Prestazione:
-32.52%
1 anno Prestazione:
-30.08%
Intervallo 1D:
$20.08
$20.81
Intervallo di 1 settimana:
$19.16
$20.81
Portata 52W:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.69 | 10.49B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
585.08 | 209.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.18 | 57.75B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.62 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.92 | 36.23B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
41.25 | 31.82B | 27.43B | 1.27B | 1.01B | 1.5829 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Downgrade | Argus | Buy → Hold |
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Is Baxter International Inc. stock affected by interest rate hikesJuly 2025 Price Swings & Safe Capital Investment Plans - ulpravda.ru
Is Baxter International Inc. stock vulnerable to regulatory risksExit Point & Fast Moving Market Watchlists - ulpravda.ru
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address - PharmiWeb.com
Baxter partnership - The Medical University of South Carolina
Signal Recap: Can Baxter International Inc. stock weather global recession2025 Price Targets & High Win Rate Trade Alerts - ulpravda.ru
MUSC Health and Baxter partner to enhance patient care with technology - Investing.com India
Will Baxter International Inc. stock see insider accumulationTrade Entry Summary & High Return Trade Guides - ulpravda.ru
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges - Business Wire
Fund Update: 4,404,874 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Baxter to Present at J.P. Morgan 2026 Healthcare Conference - MarketScreener
How to watch Baxter’s CEO at the 2026 J.P. Morgan healthcare conference - Stock Titan
New fraud claims filed in federal lawsuits against IV pump company - KMOV
Baxter International (NYSE:BAX) Given New $23.00 Price Target at Evercore ISI - MarketBeat
The Truth About Baxter International (NYSEreplacing with BCRX): Is This Biotech Underdog About To - AD HOC NEWS
Evercore ISI Adjusts Price Target on Baxter International to $23 From $24 - MarketScreener
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $24 - 富途牛牛
Artisan Mid Cap Value Fund’s Views on Baxter International (BAX) - Insider Monkey
How Investors Are Reacting To Baxter (BAX) Debt Tender Offers And Smart Infusion EMR Data - simplywall.st
Assessing Baxter International (BAX) Valuation After Recent Share Price Momentum And Margin Concerns - Yahoo Finance
How Investors May Respond To Baxter (BAX) Retiring Near‑Term Debt And Advancing Connected Infusion Therapy - Yahoo Finance
The Truth About Baxter International Inc.: Is This ‘Boring’ Stock a Secret Power Play? - AD HOC NEWS
Baxter International (BAX) and Vaneck Gold Miners ETF (GDX) top the Bull Strangle watch list for next week - Barchart.com
Baxter International Inc Stock Price Live, Charts & News - The Economic Times
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What do analysts think about Baxter International Inc. (BAX)? - MSN
What Do Analysts Think About Baxter International Inc. (BAX)? - Insider Monkey
Who Owns Baxter International? Top Shareholders and Recent Insider Trades - TIKR.com
IV Bags Market to See Massive Growth with Baxter, B. Braun, Fresenius Kabi, and Terumo - openPR.com
Opportunities and Competition in the $1.19 Billion U.S. IV - GlobeNewswire
Opportunities and Competition in the $1.19 Billion U.S. IV Bags Market, 2025-2033, Featuring Baxter International, Kraton, Technoflex, B. Braun Medical, Sippex IV Bags and More - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - 富途牛牛
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant - FinancialContent
Reasons to Retain Baxter International Stock in Your Portfolio Now - TradingView — Track All Markets
Insider Sell: Will Baxter International Inc stock outperform international peersWeekly Trade Report & Weekly Stock Performance Updates - moha.gov.vn
Baxter International Sees Unusually High Options Volume (NYSE:BAX) - MarketBeat
How Investors Are Reacting To Baxter International (BAX) Novum LVP Infusion Pump Class Action Allegations - Sahm
Baxter International (BAX) Concludes Tender Offers with Final Se - GuruFocus
Baxter International completes final settlement of tender offers for senior notes - Investing.com India
Baxter International completes final settlement of tender offers for senior notes By Investing.com - Investing.com South Africa
Baxter International Completes Cash Tender Offers, Cuts Debt - TipRanks
Baxter International Finalizes Tender Offers Settlement - TradingView — Track All Markets
Baxter International Inc. Effects the Final Settlement of the Company?s Previously Announced Cash Tender Offers - marketscreener.com
Argus Research Downgrades Baxter International Inc. (BAX)’s Rating To Hold Following Dividend Cut - MSN
Risks Report: Is Baxter International Inc. stock a dividend growth opportunityCPI Data & Real-Time Sentiment Analysis - Улправда
A. D. Beadell Investment Counsel Inc. Takes $892,000 Position in Baxter International Inc. $BAX - Defense World
Is Baxter International Inc. stock a dividend growth opportunityJuly 2025 Analyst Calls & Weekly High Conviction Ideas - ulpravda.ru
Why pension funds invest in Baxter International Inc. stockJuly 2025 Trade Ideas & Daily Stock Trend Reports - ulpravda.ru
Baxter (BAX): Reassessing Valuation as Novum Infusion Pump Class Action Lawsuits Escalate - simplywall.st
Fiduciary Alliance LLC Grows Position in Baxter International Inc. $BAX - Defense World
U.S. Intravenous Solutions Market Is Going to Boom |Baxter International Inc., ICU Medical, Inc., Braun Melsungen Ag - openPR.com
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.26%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):